diaDexus

diaDexus is a privately held biotechnology company based in the United States, specializing in the discovery, development, and commercialization of diagnostic products. The company is known for its lead product, the PLAC Test, which measures Lp-PLA2, an enzyme linked to vascular inflammation and critical in assessing the risk of coronary heart disease and ischemic stroke associated with atherosclerosis. This test is notable for being the only FDA-cleared blood test designed to aid in risk assessment for these cardiovascular conditions. In addition to the PLAC Test, diaDexus develops a range of diagnostic test kits for various health conditions, including liver disease, cancer markers, renal disease, diabetes, and electrolyte imbalances. The company primarily operates in the United States, with additional presence in Europe and other regions, contributing to its overall revenue.